The Doctor’s Advocate | First Quarter 2024
Foundation News

Spotlight on Foundation Grants: OR Crisis Checklists

In 2022, The Doctors Company Foundation sponsored a project by Ariadne Labs (a joint center for health systems innovation at the Harvard T.H. Chan School of Public Health and Brigham & Women’s Hospital) to update and expand its OR Crisis Checklists (ORCCs).

Originally created in 2011, the ORCCs improve clinicians’ ability to rescue patients from complications and minimize harm. With this update, the project team accomplished the key objective of developing a second generation OR checklist compendium with substantially increased content and functionality. The checklists are now available in online and printable versions. The online version includes an editing tool that allows users to modify the material to conform to local resources, practices, and standards.

Learn more about the Foundation’s work to fund patient safety research, education, and training.

The Doctor’s Advocate is published by The Doctors Company to advise and inform its members about loss prevention and insurance issues.

The guidelines suggested in this newsletter are not rules, do not constitute legal advice, and do not ensure a successful outcome. They attempt to define principles of practice for providing appropriate care. The principles are not inclusive of all proper methods of care nor exclusive of other methods reasonably directed at obtaining the same results.

The ultimate decision regarding the appropriateness of any treatment must be made by each healthcare provider considering the circumstances of the individual situation and in accordance with the laws of the jurisdiction in which the care is rendered.

The Doctor’s Advocate is published quarterly by Corporate Communications, The Doctors Company. Letters and articles, to be edited and published at the editor’s discretion, are welcome. The views expressed are those of the letter writer and do not necessarily reflect the opinion or official policy of The Doctors Company. Please sign your letters, and address them to the editor.